Anfield Capital Management, LLC

Position in JNJ — Johnson & Johnson

CIK 1602020 IRVINE, CA

Position in JNJ

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$83,598

+$40,967 QoQ

Shares Held

342

+66.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Anfield Capital Management, LLC holds $889,493 across 12 Drug Manufacturers - General names. JNJ ranks #4 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	281	$258,455
2	MRK	Merck & Co., Inc.	1,338	$160,948
3	GSK	GSK plc	1,852	$102,211
4	JNJ	Johnson & Johnson This page	342	$83,598
5	AZN	Astrazeneca PLC	385	$75,929
6	PFE	Pfizer Inc	2,543	$71,407
7	SNY	Sanofi	1,286	$61,959
8	NVS	Novartis AG	284	$43,381

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$83,598	342	+66.0%	Shares	Defined	2026-05-12
2025-12-31	$42,631	206	+40.1%	Shares	Defined	2026-02-03
2025-09-30	$27,256	147	-38.2%	Shares	Defined	2025-11-12
2025-06-30	$36,354	238	+24.6%	Shares	Defined	2025-08-11
2025-03-31	$31,675	191	0.0%	Shares	Defined	2025-05-13
2024-12-31	$27,622	191	-2.6%	Shares	Defined	2025-02-05
2024-09-30	$31,763	196	+49.6%	Shares	Defined	2024-11-08
2024-06-30	$19,146	131	+991.7%	Shares	Defined	2024-07-31
2024-03-31	$1,898	12	-99.5%	Shares	Defined	2024-05-09
2021-12-31	$391,066	2,286	-3.2%	Shares	Defined	2022-02-03
2021-09-30	$381,301	2,361	+3.3%	Shares	Defined	2021-11-04
2021-03-31	$375,704	2,286	+0.5%	Shares	Defined	2021-05-10
2020-12-31	$357,882	2,274	0.0%	Shares	Defined	2021-02-10
2020-09-30	$338,553	2,274	-73.4%	Shares	Defined	2020-11-12
2020-06-30	$1,203,933	8,561	+0.8%	Shares	Defined	2020-08-11
2020-03-31	$1,113,555	8,492	—	Shares	Defined	2020-05-07
No filing history on record for this holder in this stock.